WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Wednesday, September 23, 2020 
Add Press Release News | News Feeds Feeds | Email This News Email

Global Biosimilars Markets: Opportunity Analysis and Industry Forecast to 2026
Saturday, August 15, 2020

DUBLIN, Aug. 7, 2020 /PRNewswire/ -- The "Biosimilars Market by Product, by Manufacturing & Indication, by Geography Global Opportunity Analysis and Industry Forecast up to 2026" report has been added to's offering.

The market is driven by factors such as the rising prevalence of chronic diseases such as cancer and diabetes supplement the growing demands of pharmaceutical drugs. However, market growth is limited by manufacturing complexities and resistance from biological manufacturers. Furthermore, the growth of the biosimilars market is hampered with multiple factors including the lack of regulatory guidelines, consumers' brand preferences, the reluctance of physicians to prescribed biosimilars, and the high capital required for research and development.

Based on the parameter of manufacturing, the market of Biosimilars is segmented into two segments:

    --  In-house manufacturing
    --  Contract manufacturing

The in-house manufacturing segment makes up for the larger market share, while the contract manufacturing segment is expected to witness the highest CAGR during the forecasting period.

Based on the product, the biosimilars market monoclonal antibody industry is prominently segmented into trastuzumab, infliximab, rituximab, adalimumab, and other monoclonal antibodies. The infliximab segment accounted for the largest biosimilars market share in 2019. The growing prevalence of autoimmune diseases drives market growth.

Based on the indication, the market is segregated on the basis of:

    --  Oncology
    --  Blood Disorder
    --  Offsite Treatment
    --  Infectious Diseases
    --  Chronic Diseases
    --  Autoimmune Disease
    --  Other Diseases

The oncology segment accounts for a major share of the biosimilars market. The large share of this segment can be attributed to the high incidence of cancer across the globe.

Some of the major players in the domain of Biosimilars are Probiomed, Boehringer Ingelheim, Apotex, Fresenius Kabi, Gedeon Richter, Mabxience, Amega Biotech, Biocad, Coherus Biosciences, Stada Arzneimittel AG, Dr. Reddy's Laboratories, Mylan, Samsung Biologics, Amgen, Biocon, Celltrion, Teva Pharmaceutical, Eli Lilly, Pfizer, and Sandoz.

By Geography, the market of Biosimilars is further classified into North America, Europe, the Asia Pacific, and the rest of the World. North America accounted for the largest share. There are two important factors which are the driving forces behind the growth of Biosimilars market giving it CAGR of 23.9% during the forecast period.

These two factors are:

    --  Lower pricing than competing biologics
    --  Rising incidence of chronic diseases

There are a lot of opportunities in emerging countries and this report will help in understanding the current market dynamics, changing needs, and innovations that might be needed to make the user experience enriching.

Report Scope

    --  This report would be the foundation for any research on the Biosimilars,
        vendor capabilities, SWOT of the sensors, and organized framework for
        data analysis for further advanced innovation.
    --  This piece of the report would be the backbone for exhaustive research
        and a tool for the upcoming innovations and technologies. This gives an
        idea about the major competitors in the market, their journey, and the
        competitive edge which one should have to beat other players in the
    --  The report contains qualitative analysis of the Biosimilars market and
        the opportunities which can be leveraged by the market in the current
    --  The market report would be delving into deep insights regarding the
        technological innovations.

Companies Mentioned

    --  Probiomed
    --  Boehringer Ingelheim
    --  Apotex
    --  Fresenius Kabi
    --  Gedeon Richter
    --  Mabxience
    --  Amega Biotech
    --  Biocad
    --  Coherus Biosciences
    --  Stada Arzneimittel AG
    --  Dr. Reddy's Laboratories
    --  Mylan
    --  Samsung Biologics
    --  Amgen
    --  Biocon
    --  Celltrion
    --  Teva Pharmaceutical
    --  Eli Lilly
    --  Pfizer
    --  Sandoz

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Network Solutions Provider, a Leader in Business Technology Optimization and Security, and CyGlass Form a Strategic Partnership to Include CyGlass' Network Defense as a Service Solution in its Product Portfolio | Sep 23, 2020
Nav Nuance and Microsoft announce the integration of Dragon Ambient eXperience and Microsoft Teams for virtual telehealth consults | Sep 23, 2020
Nav Surgical Robotic Systems Market to Reach USD 15.01 Bn, Globally, by 2027 at 13.7% CAGR: Allied Market Research | Sep 23, 2020
Nav Financial Technology Industry Titans Nellie Levchin and Sim Tshabalala Join Motive Partners' Global Advisory Council | Sep 23, 2020
Nav Luxury Institute: Data Privacy is a Brand Reputation Issue, Not a Compliance Issue | Sep 23, 2020
Nav Veterinary Software Market to Reach $2.08 Bn, Globally, by 2027 at 6.1% CAGR, Says Allied Market Research | Sep 23, 2020
Nav Martin UAV Contracted to Support Deployed Marines | Sep 23, 2020
Nav Consumption Volume and Market Value Trends in the Global Gouda Market | Sep 23, 2020
Nav YASH Technologies announces partnership with Snowflake | Sep 23, 2020
Nav RSIP Vision Launches a New Knee Segmentation and Landmark Detection from X-ray Module | Sep 23, 2020

Submit News | View More News View More News